Curable composition and its uses
A curable composition with (meth)acrylates, diaryl iodonium salts, and latent amine catalysts addresses incomplete curing and substrate corrosion issues, offering heat and radiation curing capabilities for strong adhesion in electronic device manufacturing.
Patent Information
- Application Number
- KR1020237039731
- Authority / Receiving Office
- KR · KR
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2021-05-21
- Publication Date
- 2026-11-06
- Estimated Expiration
- 2041-05-21
AI Technical Summary
Conventional UV-curable adhesives face issues with incomplete curing in shadow regions due to light blockage, leading to problems like corrosion and peeling, while cationic curing systems suffer from moisture sensitivity and substrate corrosion on metal or inorganic materials.
A curable composition comprising (meth)acrylates, diaryl iodonium salts, and latent amine catalysts, which can be heat-cured at low temperatures, providing good adhesive strength and allowing for both heat and radiation curing.
The composition ensures complete curing even in shadow regions and exhibits high adhesive strength on various substrates, preventing corrosion and peeling, and can be used in manufacturing electronic devices.
Smart Images

Figure 112023128301082-PCT00001
Abstract
Description
Technology Field
[0001] The present invention relates to a curable composition, a cured product, and uses thereof. Background Technology
[0002] Currently, UV-curable adhesives have been successfully applied in various fields of industrial assembly, particularly in high-tech industries requiring rapid assembly, such as the manufacturing of electronic devices and optical instruments. UV-curable adhesives are also widely used in general product sectors, such as the manufacturing of glass furniture, toys, jewelry, and other decorative items.
[0003] However, in some specific applications using conventional UV-curable adhesives, several problems may be encountered. For example, shadow regions—areas where light cannot pass through or penetrate—may exist between the liquid crystal panel and the substrate. Since UV / visible light cannot pass through these areas, the adhesive cannot fully cure, which can lead to problems such as corrosion, aging fatigue, or peeling of unbonded edges.
[0004] In the case of free radical curing systems, photoradical generators and (meth)acrylate resins are the main components; while these systems have the characteristic of curing rapidly after UV irradiation, they generally have problems such as low adhesive strength. Meanwhile, cationic curing systems consist of photoacid-forming agents such as diaryl iodonium salts and triarylsulfonium salts, and epoxy resins, oxetane resins, vinyl ether resins, etc., which have cationic polymerization characteristics, and the photoacid-forming agent generates acid upon light irradiation to cure the cationic polymerizable resin. In the case of cationic curing, the system has characteristics such as rapid curing and high adhesive strength, but curing defects occur due to moisture or subtle basic stains on the surface of the substrate, and when the system is used on substrates made of metal or inorganic materials, it has problems such as causing corrosion because strong acid remains in the system. The problem to be solved
[0005] In the above view, the object of the present invention is to provide a curable composition that can be heat-cured at a temperature of less than 100°C and exhibits good adhesive strength to various substrates upon curing. Another object of the present invention is to provide a curable composition that is heat-curable and radiation-curable and exhibits good adhesive strength to various substrates upon curing. means of solving the problem
[0006] A curable composition comprising the following is disclosed herein:
[0007] (A) One or more (meth)acrylates;
[0008] (B) one or more diaryl iodonium salts; and
[0009] (C) One or more potential amine catalysts.
[0010] In addition, a cured product of a curable composition according to the present invention is disclosed herein.
[0011] In addition, articles comprising a cured product of a curable composition according to the present invention are disclosed herein.
[0012] In addition, an electronic device comprising an article according to the present invention is disclosed herein.
[0013] In addition, the use of the curable composition and articles according to the present invention in the manufacture of electronic devices is disclosed herein. Specific details for implementing the invention
[0014] Other features and modes of this gist are explained in more detail below.
[0015] Those skilled in the art should understand that the present invention is merely a description of exemplary embodiments and is not intended to limit the broader aspects of the invention. Each aspect described so far may be combined with any other aspects unless otherwise clearly indicated. In particular, any feature described as preferred or advantageous may be combined with any other feature described as preferred or advantageous.
[0016] Unless otherwise specified, in the context of the present invention, terms used shall be interpreted according to the following definitions.
[0017] Unless otherwise specified, the terms “indefinite article” and “definite article” as used herein include both singular and plural referents.
[0018] As used herein, the terms “including” and “include” are synonymous with “including,” “to include,” or “containing,” and are inclusive or open and do not exclude additional unquoted members, elements, or process steps.
[0019] As used herein, the term "room temperature" means a temperature of about 20°C to about 25°C, preferably about 25°C.
[0020] Unless otherwise specified, a citation of a numerical endpoint includes not only the cited endpoint but also all numbers and fractions contained within each range.
[0021] All references cited in this specification are incorporated herein by reference in their entirety.
[0022] Unless otherwise defined, all terms used in the present invention, including technical and scientific terms, have the same meaning as commonly understood by a person skilled in the art to which the present invention pertains.
[0023] In one embodiment, the present invention generally relates to a curable composition comprising the following:
[0024] (A) One or more (meth)acrylates;
[0025] (B) one or more diaryl iodonium salts; and
[0026] (C) One or more potential amine catalysts.
[0027] (A) (Met)acrylate
[0028] According to the present invention, a curable composition comprises (A) one or more (meth)acrylates.
[0029] Component (A) is selected from monofunctional (meth)acrylate monomers, polyfunctional (meth)acrylate monomers and their oligomers.
[0030] Examples of monofunctional (meth)acrylate monomers used as component (A) in the present invention are, but are not limited to, methyl (meth)acrylate, (meth)acrylic acid, ethyl (meth)acrylate, n-propyl (meth)acrylate, isopropyl (meth)acrylate, n-butyl (meth)acrylate, isobutyl (meth)acrylate, tert-butyl (meth)acrylate, n-pentyl (meth)acrylate, n-hexyl (meth)acrylate, cyclohexyl (meth)acrylate, n-heptyl (meth)acrylate, n-octyl (meth)acrylate, 2-ethylhexyl (meth)acrylate, nonyl (meth)acrylate, decyl (meth)acrylate, dodecyl (meth)acrylate, tricyclodecanyl (meth)acrylate, and dicyclopenthenyl Includes (meth)acrylate, phenyl (meth)acrylate, tolyl (meth)acrylate, benzyl (meth)acrylate, 2-methoxyethyl (meth)acrylate, 3-methoxybutyl (meth)acrylate, 2-hydroxyethyl (meth)acrylate, 2-hydroxypropyl (meth)acrylate, stearyl (meth)acrylate, glycidyl (meth)acrylate, 2-phenoxyethyl acrylate, 2-aminoethyl (meth)acrylate, dimethylaminoethyl (meth)acrylate, diethylaminoethyl (meth)acrylate, and combinations thereof.
[0031] Examples of polyfunctional (meth)acrylate monomers used as component (A) in the present invention are, but are not limited to, ethoxylated trimethylolpropane triacrylate, trimethylolpropane tri(meth)acrylate, dipentaerythritol pentaacrylate, pentaerythritol triacrylate, 1,6-hexanediol diacrylate, neopentyl glycol diacrylate, pentaerythritol tetraacrylate, 1,4-butanediol diacrylate, trimethylolpropane tri(meth)acrylate, tri(propylene glycol) diacrylate, neopentyl glycol propoxylate diacrylate, diethylene glycol dimethacrylate, bisphenol A diglycidyl ether di(meth)acrylate, dicyclopentadiene dimethanol di(meth)acrylate, and tricyclodecane dimethanol Includes diacrylates and combinations thereof.
[0032] In some embodiments, a urethane (meth)acrylate oligomer may be used as component (A) in the present invention. Urethane (meth)acrylates are sufficiently known to those skilled in the art and may be obtained, for example, by the reaction of a diisocyanate, preferably an aliphatic diisocyanate, with a hydroxy(meth)acrylate, or by the reaction of a diisocyanate, preferably an aliphatic diisocyanate, with a hydroxy(meth)acrylate and a polyol.
[0033] Component (A) may be used alone or in combination with two or more different compounds.
[0034] Examples of commercially available products of ingredient (A) include SR 833S from Sartomer and PEP 9000 from Negami Chemical Industrial Co., Ltd.
[0035] According to the present invention, component (A) may be present in an amount of 50% to 95% by weight, preferably 60% to 85% by weight, with respect to the total weight of the composition.
[0036] (B) Diaryl iodonium salt
[0037] According to the present invention, the curable composition comprises (B) one or more diaryl iodonium salts.
[0038] In some embodiments, the diaryl iodonium salt may be selected from diphenyl iodonium phosphate and diphenyl iodonium borate. Examples of diphenyl iodonium phosphate are selected from (4-methylphenyl)-[4-(2-methylpropyl)phenyl]iodonium hexafluorophosphate, (4-methylphenyl)-phenyliodonium hexafluorophosphate, bis(4-tert-butylphenyl)iodonium hexafluorophosphate, bis(4-methylphenyl)iodonium hexafluorophosphate, (4-ethylphenyl)-[4-(2-methylpropyl)phenyl]iodonium hexafluorophosphate, bis(t-butylphenyl)iodonium hexafluorophosphate, and bis(3,4-dimethylphenyl)iodonium hexafluorophosphate. Examples of diphenyl iodonium borates are (4-isopropylphenyl)(p-tolyl)iodonium tetrakis(perfluorophenyl)borate, (4-methylphenyl)-(2-propane-2-ylphenyl)iodonium tetrakis(2,3,4,5,6-pentafluorophenyl)boranide, bis(2-methylphenyl)iodonium tetrakis(2,3,4,5,6-pentafluorophenyl)boranide, (4-methylphenyl)-[4-(2-methylpropyl)phenyl]iodonium tetrakis(2,3,4,5,6-pentafluorophenyl)boranide, bis(4-dodecylphenyl)iodonium tetrakis(2,3,4,5,6-pentafluorophenyl)boranide, bis(2-dodecylphenyl)iodonium tetrakis(2,3,4,5,6-pentafluorophenyl)boranide, (2-methylphenyl)-(2-propane-2-ylphenyl)iodonium tetrakis(2,3,4,5,6-pentafluorophenyl)boranoid, bis(2-tert-butylphenyl)iodonium tetrakis(2,3,4,5,6-pentafluorophenyl)boranoid, 1,4-di(3-phenylpropyl)-2,3-diperfluorophenyl-1,4-diiodobutadiene, butyl(triphenyl)boranoid, (4-cyclohexylphenyl)-(4-methylphenyl)iodonium, (4-hexylphenyl)-phenyliodonium tetraphenylboranoid, (4-cyclohexylphenyl)-phenyliodonium tetraphenylboranoid.
[0039] Component (B) can be used alone or in combination with two or more different compounds.
[0040] Component (B) can be manufactured using commonly known methods. Additionally, commercial products may also be available. Examples of commercially available products of Component (B) include Rhodorsil Photoinitiator 2074 from RHODIA INC. and Omnicat 250 from IGM Resins.
[0041] According to the present invention, component (B) may be present in an amount greater than 0 weight% to less than 3 weight%, preferably 0.001 weight% to 2 weight%, more preferably 0.01 weight% to 2 weight% with respect to the total weight of the composition.
[0042] In a particularly preferred embodiment, component (B) may be present in an amount greater than 1 weight percent with respect to the total weight of the composition. When component (B) is in an amount greater than 1 weight percent, the composition may be heat-cured at a temperature of 80°C or lower.
[0043] (C) Latent amine catalyst
[0044] According to the present invention, a curable composition comprises (C) one or more latent amine catalysts. A latent amine catalyst refers to an amine catalyst that is slowly released or diffuses from a barrier at room temperature. The release or diffusion of the amine catalyst may be accelerated, for example, by increasing temperature, radiation, or force.
[0045] Examples of latent amine catalysts may include, but are not limited to, amine adduct latent catalysts obtained by reaction products of amine compounds and epoxy compounds, isocyanate compounds and / or urea compounds, core-shell type latent amine catalysts, masterbatch type latent amine catalysts and combinations thereof, preferably core-shell type latent amine catalysts.
[0046] Examples of epoxy compounds used as one of the raw materials for preparing an amine adduct potential catalyst (a potential catalyst of the amine-epoxy-adduct type) may include polyglycidyl ethers obtained by the reaction between polyhydric alcohols such as bisphenol A, bisphenol F, catechol, and resorcinol and epichlorohydrin, polyglycidyl ether esters obtained by the reaction between hydroxycarboxylic acids such as p-hydroxybenzoic acid and 3-hydroxynaphthoic acid and epichlorohydrin, polyglycidyl esters obtained by the reaction between polycarboxylic acids such as phthalic acid and terephthalic acid and epichlorohydrin, and glycidyl amine compounds obtained by the reaction between 4,4'-diaminodiphenylmethane, m-aminophenol, etc. and epichlorohydrin. Additional examples may include polyfunctional epoxy compounds such as epoxidized phenol novolak resins, epoxidized cresol novolak resins, and epoxidized polyolefins, and monofunctional epoxy compounds such as butyl glycidyl ether, phenyl glycidyl ether, and glycidyl methacrylate. However, the epoxy compounds described above used as potential catalysts in the present invention are not limited to these examples.
[0047] The amine compound used as another raw material for preparing the amine adduct potential catalyst may be any compound having one or more active hydrogens in the molecule capable of reacting with an epoxy group and having one or more functional groups selected from primary, secondary, and tertiary amino groups in the molecule. Examples of such amine compounds will be shown below. Examples may include aliphatic amines such as diethylenetriamine, triethylenetetraamine, n-propylamine, 2-hydroxyethylaminopropylamine, cyclohexylamine, and 4,4'-diamino-dicyclohexylmethane, aromatic amine compounds such as 4,4'-diaminodiphenylmethane and 2-methylaniline, and nitrogen atom-containing heterocyclic compounds such as 2-ethyl-4-methylimidazole, 2-ethyl-4-methylimidazoline, 2,4-dimethylimidazoline, piperidine, and piperazine. However, the amine compounds described above used as potential catalysts in the present invention are not limited to these examples.
[0048] Examples of such compounds may include primary or secondary amines having a tertiary amino group in the molecule, such as amine compounds like dimethylaminopropylamine, diethylaminopropylamine, dipropylaminopropylamine, dibutylaminopropylamine, dimethylaminoethylamine, diethylaminoethylamine, and N-methylpiperazine, and imidazole compounds such as 2-methylimidazole, 2-ethylimidazole, 2-ethyl-4-methylimidazole, and 2-phenylimidazole. Additional examples include alcohols, phenols, thiols, carboxylic acids, hydrazides, etc. having a tertiary amino group within the molecule, such as 2-dimethylaminoethanol, 1-methyl-2-dimethylaminoethanol, 1-phenoxymethyl-2-dimethylaminoethanol, 2-diethylaminoethanol, 1-butoxymethyl-2-dimethylaminoethanol, 1-(2-hydroxy-3-phenoxypropyl)-2-methylimidazole, 1-(2-hydroxy-3-phenoxypropyl)-2-ethyl-4-methylimidazole, 1-(2-hydroxy-3-butoxypropyl)-2-methylimidazole, 1-(2-hydroxy-3-butoxypropyl)-2-ethyl-4-methylimidazole, 1-(2-hydroxy-3-phenoxypropyl)-2-phenylimidazoline, It may include 1-(2-hydroxy-3-butoxypropyl)-2-methylimidazoline, 2-(dimethylaminomethyl)phenol, 2,4,6-tris(dimethylaminomethyl)phenol, Nn-hydroxyethylmorpholine, 2-dimethylaminoethanethiol, 2-mercaptopyridine, 2-benzimidazole, 2-mercaptobenzimidazole, 2-mercaptobenzothiazole, 4-mercaptopyridine, N,N-dimethylaminobenzoic acid, N,N-dimethylglycine, nicotinic acid, isonicotinic acid, picolinic acid, N,N-dimethylglycine hydrazide, N,N-dimethylpropionic acid hydrazide, nicotinic acid hydrazide, and isonicotinic acid hydrazide. However, the compounds having a tertiary amino group within the molecule described above, used as potential catalysts in the present invention, are not limited to these examples.
[0049] Examples of isocyanate compounds used as additional raw materials for amine adduct potential catalysts include, but are not limited to, monofunctional isocyanate compounds such as n-butyl isocyanate, isopropyl isocyanate, phenyl isocyanate, and benzyl isocyanate, and polyfunctional isocyanate compounds such as hexamethylene diisocyanate, toluene diisocyanate, 1,5-naphthalene diisocyanate, diphenylmethane-4,4'-diisocyanate, isophorone diisocyanate, xylylene diisocyanate, paraphenylene diisocyanate, 1,3,6-hexamethylene triisocyanate, and bicycloheptane triisocyanate. Furthermore, compounds containing isocyanate groups at the ends obtained by the reaction between these polyfunctional isocyanate compounds and active hydrogen compounds may be used. Examples of compounds having an isocyanate group at the end include an adduct compound having an isocyanate group at the end obtained by the reaction between toluene diisocyanate and trimethylolpropane, and an adduct compound having an isocyanate group at the end obtained by the reaction between toluene diisocyanate and pentaerythritol. However, the compounds having an isocyanate group at the end described above used as potential amine adduct catalysts in the present invention are not limited to these examples.
[0050] Examples of urea compounds used as raw materials for manufacturing amine adduct potential catalysts include, but are not limited to, urea, urea phosphate, urea oxalate, urea acetate, diacetyl urea, dibenzoyle urea, and trimethylurea.
[0051] Commercial examples of the amine adduct potential catalysts described above include Ajicure PN-23 available from Ajinomoto FineTechno Co., Inc., Ajicure PN-40 available from Ajinomoto FineTechno Co., Inc., Ajicure PN-50 available from Ajinomoto FineTechno Co., Inc., Hardener X-3661 S available from ACR Co., Ltd., Hardener X-3670S available from ACR Co., Ltd., EH-5011S and EH5057P available from Adeka, and Ancamine available from Evonik. ® Includes 2014FG and 2337S, FXR-1121 available from T&K Toka Corporation, Fujicure FXE-1000 available from T&K Toka Corporation, and Fujicure FXR-1030 available from T&K Toka Corporation.
[0052] In addition, a core-shell type latent amine catalyst is obtained by further treating the surface of an amine adduct with an acid compound, such as a carboxylic acid compound and a sulfonic acid compound, an isocyanate compound, or an epoxy compound to form a shell of the modified product (adduct, etc.) on the surface. In addition, a masterbatch type latent amine catalyst is a core-shell type latent catalyst mixed with an epoxy resin.
[0053] Commercial examples of the core-shell type latent amine catalyst and masterbatch type latent amine catalyst described above include Fujicure FXR 1081 available from T&K Toka Corporation, Novacure HX-3722 available from Asahi Kasei Epoxy Co., Ltd., Novacure HX-3742 available from Asahi Kasei Epoxy Co., Ltd., Novacure HX-3613 available from Asahi Kasei Epoxy Co., Ltd., etc.
[0054] The latent amine catalyst can be used alone. Alternatively, a combination of two or more components can be used.
[0055] According to the present invention, component (C) may be present in an amount of 3% to 47% by weight, more preferably 7% to 40% by weight, and even more preferably 13% to 35% by weight, based on the total weight of the composition.
[0056] (D) additives
[0057] In some embodiments, the curable composition may further comprise (D) one or more additives selected from a curing reaction inhibitor, a pigment, a dye, a fluorescent dye, a heat-resistant additive, a flame retardant, a plasticizer, an adhesion promoter, a filler, and combinations thereof.
[0058] Suitable examples of curing reaction inhibitors used in the present invention include, but are not limited to, acetylene compounds selected from barbiturates, 2-methyl-3-butyn-2-ol, 2-phenyl-3-butyn-2-ol or 1-ethynyl-1-cyclohexanol; en-phosphorus compounds, such as 3-methyl-3-pentene-1-phosphorus, 3,5-dimethyl-3-hexene-1-phosphorus and combinations thereof; hydrazine compounds; phosphine compounds; mercaptan compounds; and combinations thereof.
[0059] Suitable commercially available curing reaction inhibitors include PM 182 from Henkel and 3,5-dimethyl-1-hexine-3-ol from Sigma-Aldrich Company.
[0060] Examples of useful pigments include metal oxide pigments, titanium dioxide (optionally surface-treated), zirconium oxide or cerium oxide, zinc oxide, iron oxide (black, yellow, or red), chromium oxide, manganese, inorganic, organic, reactive, and non-reactive pigments, and combinations thereof.
[0061] If necessary, the curable composition may be mixed with fillers, such as silica fillers, stabilizers, carbon black, titanium black, silane coupling agents, ion capture agents, leveling agents, antioxidants, defoaming agents, thixotropic agents, and other additives without impairing the purpose of the present invention.
[0062] In the case where the composition of the present invention includes component (D), there is no particular limitation on the amount, but an amount within the range of 0% to 10% by weight, more preferably 0.1% to 5% by weight, and even more preferably 1% to 3% by weight with respect to the total weight of the composition is preferred.
[0063] (E) Photoradical polymerization initiator
[0064] According to the present invention, the curable composition may further comprise (E) one or more photoradical polymerization initiators; if present, the curing process may subsequently be initiated by UV radiation.
[0065] In some embodiments, both photoinitiation and thermal initiation may be preferred. For example, the curing process may be initiated by UV irradiation, and in a subsequent processing step, curing may be completed by applying heat to achieve further curing.
[0066] Useful photoradical polymerization initiators include, but are not limited to, α-cleavage (type I) photoradical polymerization initiators, hydrogen extraction photoradical polymerization initiators, and combinations thereof. Examples of α-cleavage (type I) photoradical polymerization initiators are benzyl dimethyl ketal, benzoin ether, hydroxyalkyl phenyl ketone, benzoyl cyclohexanol, dialkoxyacetophenone, 1-hydroxycyclohexyl phenyl ketone, trimethylbenzoyl phosphine oxide, methylthiophenyl morpholino ketone and morpholinophenyl amino ketone, and combinations thereof. Examples of hydrogen extraction photoradical polymerization initiators are benzophenone, thioxantone, benzyl, camphorquinone, ketocoumarin, and combinations thereof.
[0067] Desirable photoradical polymerization initiators include ketone derivatives, for example, 1-hydroxycyclohexylphenyl ketone.
[0068] These photoradical polymerization initiators can be used alone or in combination of two or more types.
[0069] A useful commercially available photoradical polymerization initiator is from BASF under the trade name IRGACURE ® 184, IRGACURE ® 127, IRGACURE ® 819, IRGACURE ® 754 and IRGACURE ® 500, DAROCUR ® It can be obtained at 4265.
[0070] Generally, when a photoradical polymerization initiator is present in the composition, these compositions are cured at room temperature for a time of less than 30 seconds, preferably less than 10 seconds, more preferably less than 5 seconds at a wavelength in the range of 200 nm to 650 nm, preferably 300 nm to 500 nm, and then the heat curing process described herein is performed. As is understood, the time and wavelength curing profiles for each curable composition will vary, and various compositions may be designed to provide curing profiles suitable for a particular industrial manufacturing process.
[0071] Particularly preferably, if component (E) is present, it may be in an amount of 0% to 10% by weight, preferably 0.1% to 7% by weight, with respect to the total weight of the composition.
[0072] composition
[0073] In a particularly preferred embodiment, the curable composition comprises the following with respect to the total weight of the composition:
[0074] (A) 50% to 95% by weight, preferably 60% to 85% by weight of one or more (meth)acrylates,
[0075] (B) one or more diaryl iodonium salts in an amount greater than 0 wt% to less than 3 wt%, preferably 0.001 wt% to 2 wt%, more preferably 0.01 wt% to 2 wt%,
[0076] (C) 3 wt% to 47 wt%, more preferably 7 wt% to 40 wt%, even more preferably 13 wt% to 35 wt% of one or more latent amine catalysts,
[0077] (D) one or more additives in an amount of 0% to 10% by weight, more preferably 0.1% to 5% by weight, and even more preferably 1% to 3% by weight, and
[0078] (E) 0% to 10% by weight, preferably 0.1% to 7% by weight of one or more photoradical polymerization initiators.
[0079] Method for preparing a curable composition
[0080] The curable composition according to the present invention can be prepared at room temperature by the following steps:
[0081] (i) a step of mixing component (B) and component (E) (if present) with component (A) in a device to obtain a homogeneous mixture,
[0082] (ii) if component (D) is present, adding component (D) to the mixture obtained by step (i); and
[0083] (iii) Finally, a step of adding component (C) and uniformly stirring the mixture to obtain a composition.
[0084] The devices for mixing, stirring, dispersion, etc. are not particularly limited. Automated mortars equipped with stirrers and heaters, Henschel mixers, 3-roll mills, ball mills, planetary mixers, bead mills, etc., may be used. In addition, appropriate combinations of these devices may be used. The method for manufacturing the curable composition is not particularly limited, as long as it can yield a composition in which the components described above are uniformly mixed.
[0085] Curing profile and cured product
[0086] According to the present invention, the curable composition of the present invention may be thermocurable at a temperature preferably below 100°C, more preferably below 80°C.
[0087] In some embodiments, the curable composition of the present invention may be thermocurable at 40°C to 95°C, preferably 40°C to 85°C.
[0088] The inventors surprisingly discovered that while diaryl iodonium salts can release free radicals after heating to over 100°C, which can initiate free radical polymerization of (meth)acrylates, the reaction temperature can be significantly reduced when a potential amine catalyst is present in the reaction.
[0089] According to the present invention, when one or more photoradical polymerization initiators are present, the curable composition of the present invention may be thermocurable and radiation-curable.
[0090] In a preferred embodiment, the curable composition of the present invention may be cured by UV radiation at room temperature for a time of less than 30 seconds, preferably less than 10 seconds, more preferably less than 5 seconds, at a wavelength in the range of 200 nm to 650 nm, preferably 250 nm to 500 nm; and then heat-cured for 20 minutes to 3 hours at a temperature of less than 100 °C, preferably 60 °C to 90 °C, preferably 62 °C to 82 °C. As is understood, the time and temperature curing profiles for each adhesive composition will vary, and various compositions may be designed to provide a curing profile suitable for a particular industrial manufacturing process.
[0091] In another aspect of the present invention, a cured product of a curable composition according to the present invention is provided.
[0092] Articles, electronic devices and their uses
[0093] In another aspect of the present invention, an article is provided comprising a first substrate, a cured product, and a second substrate bonded to the first substrate through a cured product derived from a curable composition according to the present invention.
[0094] The first substrate and / or the second substrate may be a single material and a single layer, or may comprise multiple layers of the same or different materials. The layers may be continuous or discontinuous.
[0095] The substrate of the article described herein may have various characteristics including rigidity (e.g., a rigid substrate, i.e., the substrate cannot be bent using two hands, or will break if an individual attempts to bend the substrate with two hands), flexibility (e.g., a flexible substrate, i.e., the substrate can be bent using less force than that of two hands), porosity, conductivity, lack of conductivity, and combinations thereof.
[0096] The substrate of the article may be in various forms, including, for example, fibers, threads, yarns, woven fabrics, nonwoven fabrics, films (e.g., polymer films, metallized polymer films, continuous films, discontinuous films and combinations thereof), foils (e.g., metal foils), sheets (e.g., metal sheets, polymer sheets, continuous sheets, discontinuous sheets and combinations thereof) and combinations thereof.
[0097] Useful substrate materials used in the present invention are, for example, polymers (e.g., polycarbonate, ABS resin (acrylonitrile-butadiene-styrene resin), liquid crystal polymers, polyolefins (e.g., polypropylene, polyethylene, low-density polyethylene, linear low-density polyethylene, high-density polyethylene, polypropylene and oriented polypropylene, copolymers of polyolefins and other comonomers), polyether terephthalates, ethylene-vinyl acetate, ethylene-methacrylic acid ionomers, ethylene-vinyl alcohols, polyesters, for example, polyethylene terephthalate, polycarbonate, polyamides, for example, nylon-6 and nylon-6,6, polyvinyl chloride, polyvinylidene chloride, cellulose, polystyrene, and epoxy), polymer composites (e.g., composites of polymers and metals, cellulose, glass, polymers and combinations thereof), metals (aluminum, copper, zinc, lead, gold, silver, platinum, and magnesium, and metal alloys, e.g., steel (e.g., stainless steel), tin, brass, and magnesium and aluminum alloys), carbon-fiber composites, other fiber-based composites, graphene, fillers, glass (e.g., alkali-aluminosilicate strengthened glass and borosilicate glass), quartz, boron nitride, gallium nitride, sapphire, silicon, carbides, ceramics and combinations thereof, preferably liquid crystal polymers, glass and combinations thereof.
[0098] The curable composition may be applied to a substrate using any suitable application method, including, for example, automatic fine line dispensing, jet dispensing, slot die coating, roll coating, gravure coating, transfer coating, pattern coating, screen printing, spray coating, filament coating, extrusion, air knife, trailing blade, brushing, dipping, doctor blade, offset gravure coating, rotogravure coating, and combinations thereof. The curable composition may be applied as a continuous or discontinuous coating in single layers, multilayers, and combinations thereof.
[0099] Optionally, the surface of the substrate to which the curable adhesive composition is applied is treated to improve adhesion using any suitable method to improve adhesion to the substrate surface, including, for example, corona treatment, chemical treatment (e.g., chemical etching), flame treatment, abrasion, and combinations thereof.
[0100] In a further aspect of the present invention, an electronic device comprising an article of the present invention is provided.
[0101] Exemplary electronic devices include computers and computer equipment, such as printers, fax machines, scanners, keyboards, etc.; medical sensors; automotive sensors, etc.; wearable electronic devices (e.g., wristwatches and glasses), portable electronic devices (e.g., phones (e.g., cellular telephones and cellular smartphones), cameras, tablets, electronic readers, monitors (e.g., monitors used in hospitals, and by medical workers, athletes, and individuals), watches, calculators, mice, touchpads, and joysticks), computers (e.g., desktop and laptop computers), computer monitors, televisions, media players, household appliances (e.g., refrigerators, washing machines, dryers, ovens, and microwave ovens), light bulbs (e.g., incandescent, light-emitting diode, and fluorescent), and articles including visible transparent or transparent parts, glass housing structures, and protective transparent covers for displays or other optical parts.
[0102] In another aspect of the present invention, a curable adhesive composition and an article according to the present invention are used in the manufacture of electronic devices.
[0103] Examples
[0104] The following examples are intended to help those skilled in the art better understand and practice the present invention. The scope of the present invention is not limited by the examples but is defined by the appended claims. Unless otherwise specified, all parts and % are based on weight.
[0105] raw material:
[0106] SR 833S is tricyclodecane dimethanol diacrylate available from Sartomer.
[0107] PEP 9000 is a urethane (meth)acrylate available from Negami Chemical Industrial Co., Ltd.
[0108] Irgacure 184 is a 1-hydroxycyclohexyl phenyl ketone available from BASF.
[0109] Rhodorsil Photoinitiator 2074 is 4-isopropyl-4'-methyldiphenyliodonium tetrakis(pentafluorophenyl)borate available from RHODIA INC.
[0110] Omnicat 250 is 4-isobutylphenyl-4'-methylphenyliodonium hexafluorophosphate iododonium available from IGM Resins.
[0111] CPI-200K is a triarylsulfonium salt with a phosphate anion available from San-Apro Ltd.
[0112] Cyracure UVI 6976 is a mixed triarylsulfonium hexafluoroantimonate salt available from DOW.
[0113] 2-(acetyloxy)-5-iodobenzoic acid is available from Sigma Aldrich.
[0114] Iodobenzene is available from Sigma Aldrich.
[0115] Fujicure FXR 1081 is a mixture of aliphatic polyamines and cycloaliphatic polyamines available from T&K Toka Corporation.
[0116] 2E4MZ-CN is 1-cyanoethyl-2-ethyl-4-methylimidazole available from Shikoku Chemicals.
[0117] PM 182 is a barbiturate available from Henkel.
[0118] Manufacturing method:
[0119] Example 1 (Ex.1)
[0120] 0.08 g Rhodorsil Photoinitiator 2074 was mixed with 3 g SR 833S in a covered container. The mixture was stirred at room temperature for 10 minutes at a speed of 2000 rpm in a Speedmixer DAC 150.1 FVZ-K (manufactured by FlackTek, Inc.). Subsequently, 0.1 g PM 182 was added to the container, and the mixture was mixed at a speed of 1000 rpm for 5 minutes. Then, 1 g Fujicure FXR 1081 was added, and the mixture was mixed at 1000 rpm for 5 minutes. Finally, a curable composition was obtained by removing air bubbles from the homogeneous mixture using a Thinky ARV-310 mixer.
[0121] Example 2 (Ex.2)
[0122] 0.08 g Omnicat 250 was mixed with 3 g SR 833S in a covered container. The mixture was stirred at room temperature for 10 minutes at a speed of 2000 rpm using a Speedmixer DAC 150.1 FVZ-K (manufactured by FlackTek, Inc.). Subsequently, 0.1 g PM 182 was added to the container, and the mixture was mixed at a speed of 1000 rpm for 5 minutes. Then, 1 g Fujicure FXR 1081 was added, and the mixture was mixed at 1000 rpm for 5 minutes. Finally, a curable composition was obtained by removing air bubbles from the homogeneous mixture using a Thinky ARV-310 mixer.
[0123] Example 3 (Ex.3)
[0124] 0.04 g Rhodorsil Photoinitiator 2074 was mixed with 3 g SR 833S in a covered container. The mixture was stirred at room temperature for 10 minutes at a speed of 2000 rpm using a Speedmixer DAC 150.1 FVZ-K (manufactured by FlackTek, Inc.). Subsequently, 0.1 g PM 182 was added to the container, and the mixture was mixed at a speed of 1000 rpm for 5 minutes. Then, 1 g Fujicure FXR 1081 was added, and the mixture was mixed at 1000 rpm for 5 minutes. Finally, a curable composition was obtained by removing air bubbles from the homogeneous mixture using a Thinky ARV-310 mixer.
[0125] Example 4 (Ex.4)
[0126] 0.005 g Rhodorsil Photoinitiator 2074 was mixed with 3 g SR 833S in a covered container. The mixture was stirred at room temperature for 10 minutes at a speed of 2000 rpm using a Speedmixer DAC 150.1 FVZ-K (manufactured by FlackTek, Inc.). Subsequently, 0.1 g PM 182 was added to the container, and the mixture was mixed at a speed of 1000 rpm for 5 minutes. Then, 1 g Fujicure FXR 1081 was added, and the mixture was mixed at 1000 rpm for 5 minutes. Finally, a curable composition was obtained by removing air bubbles from the homogeneous mixture using a Thinky ARV-310 mixer.
[0127] Example 5 (Ex.5)
[0128] 0.08 g Rhodorsil Photoinitiator 2074 was mixed with 3 g SR 833S in a covered container. The mixture was stirred at room temperature for 10 minutes at a speed of 2000 rpm using a Speedmixer DAC 150.1 FVZ-K (manufactured by FlackTek, Inc.). Subsequently, 0.1 g PM 182 was added to the container, and the mixture was mixed at a speed of 1000 rpm for 5 minutes. Then, 0.5 g Fujicure FXR 1081 was added, and the mixture was mixed at 1000 rpm for 5 minutes. Finally, a curable composition was obtained by removing air bubbles from the homogeneous mixture using a Thinky ARV-310 mixer.
[0129] Example 6 (Ex.6)
[0130] 0.08 g Rhodorsil Photoinitiator 2074 was mixed with 3 g SR 833S in a covered container. The mixture was stirred at room temperature for 10 minutes at a speed of 2000 rpm using a Speedmixer DAC 150.1 FVZ-K (manufactured by FlackTek, Inc.). Subsequently, 0.1 g PM 182 was added to the container, and the mixture was mixed at a speed of 1000 rpm for 5 minutes. Then, 0.1 g Fujicure FXR 1081 was added, and the mixture was mixed at 1000 rpm for 5 minutes. Finally, a curable composition was obtained by removing air bubbles from the homogeneous mixture using a Thinky ARV-310 mixer.
[0131] Example 7 (Ex.7)
[0132] 1 g PEP 9000 was mixed with 2 g SR 833S in a covered container. The mixture was stirred at room temperature for 10 minutes at a speed of 2000 rpm in a Speedmixer DAC 150.1 FVZ-K (manufactured by FlackTek, Inc.). Subsequently, 0.08 g Rhodorsil Photoinitiator 2074 and 0.15 g Irgacure ® 184 was added to a container, and the mixture was mixed at a speed of 1000 rpm for 5 minutes. Then, 0.1 g PM 182 was added to the container, and the mixture was mixed at a speed of 1000 rpm for an additional 5 minutes. After that, 1 g Fujicure FXR 1081 was added, and the mixture was mixed at 1000 rpm for 5 minutes. Finally, a curable composition was obtained by removing air bubbles from the homogeneous mixture using a Thinky ARV-310 mixer.
[0133] Example 8 (Ex.8)
[0134] 1 g PEP 9000 was mixed with 2 g SR 833S in a covered container. The mixture was stirred at room temperature for 10 minutes at a speed of 2000 rpm in a Speedmixer DAC 150.1 FVZ-K (manufactured by FlackTek, Inc.). Subsequently, 0.08 g Omnicat 250 and 0.15 g Irgacure ® 184 was added to a container, and the mixture was mixed at a speed of 1000 rpm for 5 minutes. Then, 0.1 g PM 182 was added to the container, and the mixture was mixed at a speed of 1000 rpm for an additional 5 minutes. After that, 1 g Fujicure FXR 1081 was added, and the mixture was mixed at 1000 rpm for 5 minutes. Finally, a curable composition was obtained by removing air bubbles from the homogeneous mixture using a Thinky ARV-310 mixer.
[0135] Example 9 (Ex.9)
[0136] 1 g PEP 9000 was mixed with 2 g SR 833S in a covered container. The mixture was stirred at room temperature for 10 minutes at a speed of 2000 rpm in a Speedmixer DAC 150.1 FVZ-K (manufactured by FlackTek, Inc.). Subsequently, 0.08 g Rhodorsil Photoinitiator 2074 and 0.15 g Irgacure ® 184 was added to a container, and the mixture was mixed at a speed of 1000 rpm for 5 minutes. Then, 0.1 g PM 182 was added to the container, and the mixture was mixed at a speed of 1000 rpm for an additional 5 minutes. After that, 0.3 g Fujicure FXR 1081 was added, and the mixture was mixed at 1000 rpm for 5 minutes. Finally, a curable composition was obtained by removing air bubbles from the homogeneous mixture using a Thinky ARV-310 mixer.
[0137] Example 10 (Ex.10)
[0138] 1 g PEP 9000 was mixed with 2 g SR 833S in a covered container. The mixture was stirred at room temperature for 10 minutes at a speed of 2000 rpm in a Speedmixer DAC 150.1 FVZ-K (manufactured by FlackTek, Inc.). Subsequently, 0.04 g Rhodorsil Photoinitiator 2074 and 0.15 g Irgacure ®184 was added to a container, and the mixture was mixed at a speed of 1000 rpm for 5 minutes. Then, 0.1 g PM 182 was added to the container, and the mixture was mixed at a speed of 1000 rpm for an additional 5 minutes. After that, 1 g Fujicure FXR 1081 was added, and the mixture was mixed at 1000 rpm for 5 minutes. Finally, a curable composition was obtained by removing air bubbles from the homogeneous mixture using a Thinky ARV-310 mixer.
[0139] Comparative Example 1 (CEx.1)
[0140] 0.08 g Rhodorsil Photoinitiator 2074 was mixed with 3 g SR 833S in a covered container. The mixture was stirred at a speed of 2000 rpm for 10 minutes at room temperature in a Speedmixer DAC 150.1 FVZ-K (manufactured by FlackTek, Inc.) to obtain a curable composition.
[0141] Comparative Example 2 (CEx.2)
[0142] 3 g of SR 833S was prepared in a covered container. Then, 1 g of Fujicure FXR 1081 was added, and the mixture was stirred at a speed of 2000 rpm at room temperature for 10 minutes in a Speedmixer DAC 150.1 FVZ-K (manufactured by FlackTek, Inc.) to obtain the composition.
[0143] Comparative Example 3 (CEx.3)
[0144] 0.08 g CPI-200K was mixed with 3 g SR 833S in a covered container. The mixture was stirred at room temperature for 10 minutes at a speed of 2000 rpm in a Speedmixer DAC 150.1 FVZ-K (manufactured by FlackTek, Inc.). Subsequently, 0.1 g PM 182 was added to the container, and the mixture was mixed at a speed of 1000 rpm for 5 minutes. Then, 1 g Fujicure FXR 1081 was added, and the mixture was mixed at 1000 rpm for 5 minutes. Finally, the composition was obtained by removing air bubbles from the homogeneous mixture using a Thinky ARV-310 mixer.
[0145] Comparative Example 4 (CEx.4)
[0146] 0.08 g of Cyracure UVI 6976 was mixed with 3 g of SR 833S in a covered container. The mixture was stirred at room temperature for 10 minutes at a speed of 2000 rpm in a Speedmixer DAC 150.1 FVZ-K (manufactured by FlackTek, Inc.). Subsequently, 0.1 g of PM 182 was added to the container, and the mixture was mixed at a speed of 1000 rpm for 5 minutes. Then, 1 g of Fujicure FXR 1081 was added, and the mixture was mixed at 1000 rpm for 5 minutes. Finally, the composition was obtained by removing air bubbles from the homogeneous mixture using a Thinky ARV-310 mixer.
[0147] Comparative Example 5 (CEx.5)
[0148] 0.08 g iodobenzene was mixed with 3 g SR 833S in a covered container. The mixture was stirred at room temperature for 10 minutes at a speed of 2000 rpm in a Speedmixer DAC 150.1 FVZ-K (manufactured by FlackTek, Inc.). Subsequently, 0.1 g PM 182 was added to the container, and the mixture was mixed at a speed of 1000 rpm for 5 minutes. Then, 1 g Fujicure FXR 1081 was added, and the mixture was mixed at 1000 rpm for 5 minutes. Finally, the composition was obtained by removing air bubbles from the homogeneous mixture using a Thinky ARV-310 mixer.
[0149] Comparative Example 6 (CEx.6)
[0150] 0.08 g of 2-(acetyloxy)-5-iodobenzoic acid was mixed with 3 g of SR 833S in a covered container. The mixture was stirred at room temperature for 10 minutes at a speed of 2000 rpm using a Speedmixer DAC 150.1 FVZ-K (manufactured by FlackTek, Inc.). Subsequently, 0.1 g of PM 182 was added to the container, and the mixture was mixed at a speed of 1000 rpm for 5 minutes. Then, 1 g of Fujicure FXR 1081 was added, and the mixture was mixed at 1000 rpm for 5 minutes. Finally, a curable composition was obtained by removing air bubbles from the homogeneous mixture using a Thinky ARV-310 mixer.
[0151] Comparative Example 7 (CEx.7)
[0152] 0.08 g Rhodorsil Photoinitiator 2074 was mixed with 3 g SR 833S in a covered container. The mixture was stirred at room temperature for 10 minutes at a speed of 2000 rpm in a Speedmixer DAC 150.1 FVZ-K (manufactured by FlackTek, Inc.). Subsequently, 0.1 g PM 182 was added to the container, and the mixture was mixed at a speed of 1000 rpm for 5 minutes. Then, 0.5 g 2E4MZ-CN was added, and the mixture was mixed at 1000 rpm for 5 minutes. Finally, a curable composition was obtained by removing air bubbles from the homogeneous mixture using a Thinky ARV-310 mixer.
[0153] Comparative Example 8 (CEx.8)
[0154] 1 g PEP 9000 was mixed with 2 g SR 833S in a covered container. The mixture was stirred at room temperature for 10 minutes at a speed of 2000 rpm in a Speedmixer DAC 150.1 FVZ-K (manufactured by FlackTek, Inc.). Subsequently, 0.08 g Rhodorsil Photoinitiator 2074 and 0.01 g Irgacure ® 184 was added to a container, and the mixture was mixed at a speed of 1000 rpm for 5 minutes. Finally, a curable composition was obtained by removing air bubbles from the homogeneous mixture using a Thinky ARV-310 mixer.
[0155] Comparative Example 9 (CEx.9)
[0156] 1 g PEP 9000 was mixed with 2 g SR 833S in a covered container. The mixture was stirred at room temperature for 10 minutes at a speed of 2000 rpm in a Speedmixer DAC 150.1 FVZ-K (manufactured by FlackTek, Inc.). Subsequently, 0.01 g Irgacure ®184 was added to a container, and the mixture was mixed at a speed of 1000 rpm for 5 minutes. Then, 1 g of Fujicure FXR 1081 was added, and the mixture was mixed at 1000 rpm for 5 minutes. Finally, the composition was obtained by removing air bubbles from the homogeneous mixture using a Thinky ARV-310 mixer.
[0157] Comparative Example 10 (CEx.10)
[0158] 1 g PEP 9000 was mixed with 2 g SR 833S in a covered container. The mixture was stirred at room temperature for 10 minutes at a speed of 2000 rpm in a Speedmixer DAC 150.1 FVZ-K (manufactured by FlackTek, Inc.). Subsequently, 0.08 g Cyracure UVI 6976 and 0.15 g Irgacure ® 184 was added to a container, and the mixture was mixed at a speed of 1000 rpm for 5 minutes. Then, 0.1 g PM 182 was added to the container, and the mixture was mixed at a speed of 1000 rpm for an additional 5 minutes. After that, 1 g Fujicure FXR 1081 was added, and the mixture was mixed at 1000 rpm for 5 minutes. Finally, the composition was obtained by removing air bubbles from the homogeneous mixture using a Thinky ARV-310 mixer.
[0159] Test method:
[0160] Differential Scanning Calorimetry (DSC)
[0161] Each formulation from Ex.1 to Ex.6 and CEx.1 to CEx.7 was measured using a dynamic DSC Q2000 instrument to determine the curing temperature, wherein the measurement conditions were as follows: a scanning temperature range of 40°C to 250°C at 10°C / min. The peak temperatures are recorded in Table 1.
[0162] A DSC peak temperature of less than 100 ℃ may be acceptable.
[0163] Die shear strength of the hardened product
[0164] The die shear strength (DSS) of the cured products was measured at room temperature using a DAGE4000 (manufactured by Nordson Corporation). The compositions of the present invention and the comparative examples were coated to a thickness of 0.8 mm onto a 3 x 3 mm² glass top substrate. Subsequently, the glass top substrate was placed on a polyamide substrate. All samples of each composition from Ex.1 to Ex.6 and CEx.1 to CEx.7 were cured in an 80°C oven for 1 hour. All samples of each composition from Ex.7 to Ex.10 and CEx.8 and CEx.10 were cured under UV radiation of 1100 mw / cm² at a wavelength of 365 nm LED light for 2 seconds, followed by heat curing in an oven at 80°C for 1 hour. No pressure was applied. Each sample was tested 8 times under the same conditions, and the average DSS was calculated and recorded using the simple average method to eliminate errors. The test results are shown in Table 1 and Table 2.
[0165] From Ex.1 to Ex.6 and CEx.1 to CEx.7, DSS exceeding 5 kg may be permissible. From Ex.7 to Ex.10 and CEx.8 and CEx.10, DSS exceeding 5 kg may be permissible.
[0166]
[0167] As can be seen from Table 1, the curable composition of the present invention exhibited a lower curing temperature (less than 100°C) than the comparative composition, and the cured product of the curable composition of the present invention exhibited good die shear strength (greater than 5 kg).
[0168] As can be seen from Table 2, the curable composition of the present invention can be thermocurable and radiation-curable and exhibited a desired die shear strength (greater than 5 kg).
[0169] Although several preferred embodiments have been described, many modifications and variations may be made in light of the foregoing teachings. Therefore, it should be understood that the present invention may be practiced differently from specifically described without departing from the scope of the appended claims.
Claims
Claim 1 A curable composition comprising: (A) one or more (meth)acrylates; (B) one or more diaryl iodonium salts; and (C) one or more latent amine catalysts. Claim 2 A curable composition according to claim 1, wherein component (A) is selected from monofunctional (meth)acrylate monomers, polyfunctional (meth)acrylate monomers, and oligomers thereof. Claim 3 In claim 2, the monofunctional (meth)acrylate monomer is methyl (meth)acrylate, (meth)acrylic acid, ethyl (meth)acrylate, n-propyl (meth)acrylate, isopropyl (meth)acrylate, n-butyl (meth)acrylate, isobutyl (meth)acrylate, tert-butyl (meth)acrylate, n-pentyl (meth)acrylate, n-hexyl (meth)acrylate, cyclohexyl (meth)acrylate, n-heptyl (meth)acrylate, n-octyl (meth)acrylate, 2-ethylhexyl (meth)acrylate, nonyl (meth)acrylate, decyl (meth)acrylate, dodecyl (meth)acrylate, tricyclodecanyl (meth)acrylate, dicyclopentenyl (meth)acrylate, phenyl A curable composition selected from (meth)acrylate, tolyl (meth)acrylate, benzyl (meth)acrylate, 2-methoxyethyl (meth)acrylate, 3-methoxybutyl (meth)acrylate, 2-hydroxyethyl (meth)acrylate, 2-hydroxypropyl (meth)acrylate, stearyl (meth)acrylate, glycidyl (meth)acrylate, 2-phenoxyethyl acrylate, 2-aminoethyl (meth)acrylate, dimethylaminoethyl (meth)acrylate, diethylaminoethyl (meth)acrylate, and combinations thereof. Claim 4 In claim 2, the polyfunctional (meth)acrylate monomer is selected from ethoxylated trimethylolpropane triacrylate, trimethylolpropane tri(meth)acrylate, dipentaerythritol pentaacrylate, pentaerythritol triacrylate, 1,6-hexanediol diacrylate, neopentyl glycol diacrylate, pentaerythritol tetraacrylate, 1,4-butanediol diacrylate, trimethylolpropane tri(meth)acrylate, tri(propylene glycol) diacrylate, neopentyl glycol propoxylate diacrylate, diethylene glycol dimethacrylate, bisphenol A diglycidyl ether di(meth)acrylate, dicyclopentadiene dimethanol di(meth)acrylate, tricyclodecane dimethanol diacrylate, and combinations thereof. Curable composition. Claim 5 A curable composition according to any one of claims 1 to 4, wherein component (B) is selected from diphenyl iodonium phosphate, diphenyl iodonium borate, and combinations thereof. Claim 6 A curable composition according to any one of claims 1 to 4, wherein component (C) is selected from an amine adduct potential amine catalyst; a core-shell type potential amine catalyst; a masterbatch type potential amine catalyst; and a combination thereof. Claim 7 A curable composition according to any one of claims 1 to 4, wherein the composition further comprises (D) one or more additives selected from a curing reaction inhibitor, a pigment, a dye, a fluorescent dye, a heat-resistant additive, a flame retardant, a plasticizer, an adhesion promoter, a filler, and combinations thereof. Claim 8 A curable composition according to any one of claims 1 to 4, wherein the composition is thermosetting. Claim 9 A curable composition according to any one of claims 1 to 4, wherein the composition further comprises (E) one or more photoradical polymerization initiators. Claim 10 A curable composition according to claim 9, wherein the photoradical polymerization initiator is selected from α-fission photoradical polymerization initiators, hydrogen extraction photoradical polymerization initiators, and combinations thereof. Claim 11 In claim 9, a curable composition in which the composition is thermosetting and radiationsetting. Claim 12 A curable composition according to any one of claims 1 to 4, wherein component (A) is present in an amount of 50% to 95% by weight with respect to the total weight of the composition. Claim 13 A curable composition according to any one of claims 1 to 4, wherein component (B) is present in an amount greater than 0 weight% and less than 3 weight% with respect to the total weight of the composition. Claim 14 A curable composition according to any one of claims 1 to 4, wherein component (C) is present in an amount of 3% to 47% by weight relative to the total weight of the composition. Claim 15 A curable composition according to claim 7, wherein component (D) is present in an amount of 0% to 10% by weight relative to the total weight of the composition. Claim 16 A curable composition according to claim 9, wherein component (E) is present in an amount of 0% to 10% by weight relative to the total weight of the composition. Claim 17 A cured product of a curable composition according to any one of claims 1 to 4. Claim 18 An article comprising: a first substrate, a cured product according to claim 17, and a second substrate bonded to the first substrate through the cured product. Claim 19 An electronic device comprising an article pursuant to Article 18. Claim 20 A curable composition used in the manufacture of an electronic device, in any one of claims 1 to 4.
Citation Information
Patent Citations
Photocurable composition
JP1997235310A
Latent curing type epoxy resin composition of photo-heat combination type
JP2009079216A
Resin composition
JP2014077024A
Active ray-curable adhesive composition
JP2015086371A
Curable composition
KR1020050107590A
